Open report — full analysis, no account required.
Sign up to generate reports and read filings that aren't on the open list.
Get notified when MOVE files again. Create a free account and we'll email you the moment its next filing is analyzed.
Get filing alertsRed Flags Detected
- Delisting (new) — Company remains at risk of delisting if any Nasdaq rule violation occurs during the one-year monitoring period with no grace period for cure.
Corvex regains Nasdaq compliance but enters one-year probation with no grace for violations
Filed April 9, 2026 · Period ending April 7, 2026 · ~1 min read
Key Changes
-
high
Corvex restored compliance with Nasdaq's minimum stockholders' equity requirement on April 7, 2026, after receiving a deficiency notice in October 2025 and an extension through March 30, 2026.
8-K: Nasdaq Compliance view on EDGAR → -
high
Nasdaq imposed a mandatory one-year monitoring period starting April 7, 2026, subjecting the company to heightened scrutiny of all listing rule compliance.
8-K: Panel Monitor verify on EDGAR → -
high
Any Nasdaq rule violation during the monitoring period triggers immediate delisting proceedings with no opportunity to submit a compliance plan or receive additional cure time—only a Panel hearing request is allowed.
8-K: No Grace Period view on EDGAR →
Summary
Corvex has cleared a critical hurdle by regaining compliance with Nasdaq's minimum stockholders' equity requirement, resolving a deficiency that began in October 2025. However, the company now operates under a one-year probationary period with significantly stricter oversight.
Unlike typical compliance scenarios where companies receive time to cure deficiencies, Corvex will face immediate delisting proceedings if it violates any Nasdaq listing rule during this monitoring window—its only recourse would be requesting a Panel hearing. Retail investors should understand this is a double-edged outcome: the immediate delisting threat is removed, but the company remains on thin ice.
Any financial deterioration, reporting delays, or governance missteps could trigger swift delisting action. Watch the company's quarterly filings closely over the next year, particularly stockholders' equity levels and any disclosures about Nasdaq communications. The April 2027 end of the monitoring period will be a key milestone for assessing whether Corvex has stabilized its listing status.
Thanks — your feedback helps us improve report quality.
Figures/quotes linked to EDGAR · Narrative written by AI · Jun 3, 2026 · How we verify